Idiopathic pulmonary fibrosis (IPF) is a progressive scarring disease arising from impaired
regeneration of the alveolar epithelium after injury. During regeneration, type 2 alveolar …

Recent genetic and genomic advancements have elucidated the complex etiology of
idiopathic pulmonary fibrosis (IPF) and other progressive fibrotic interstitial lung diseases …

Pulmonary fibrosis comprises a range of chronic interstitial lung diseases (ILDs) that impose
a significant burden on patients and public health. Among these, idiopathic pulmonary …

It has been shown that exposure to nanoplastics (MNPs) through inhalation can induce
pulmonary toxicity, but the toxicological mechanism of MNPs on the respiratory system …

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrotic interstitial lung disease. A
barrier to develo** more effective therapies for IPF is the dearth of preclinical models that …

Background Acute lung injury or acute respiratory distress syndrome (ALI/ARDS) is a
devastating clinical syndrome with high incidence and mortality rates. IRE1α-XBP1 pathway …

Idiopathic pulmonary fibrosis (IPF) is etiologically complex, with well-documented genetic
and nongenetic origins. In this Review, we speculate that the development of IPF requires …

Hermansky-Pudlak syndrome (HPS) is a genetic disorder of endosomal protein trafficking
associated with pulmonary fibrosis in specific subtypes, including HPS-1 and HPS-2. Single …

The limited and backward diagnostic approaches elicit high mortality associated with
pulmonary fibrosis (PF) because they fail to identify injury phase of PF. Develo** a …

COVID-19 syndrome is characterized by acute lung injury, hypoxemic respiratory failure,
and high mortality. Alveolar Type 2 (AT2) cells are essential for gas exchange, repair, and …